The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(19 sites)

Belgium

ASZ Aalst, Aalst

OLVZ Aalst, Aalst

Imelda Ziekenhuis, Bonheiden

CHU Charleroi, Charleroi

Jessa Hospital Hasselt, Hasselt

Ireland

University Hospital Galway, Galway

Netherlands

OLVG Amsterdam, Amsterdam

Medisch Spectrum Twente, Thoraxcentrum, Endchede, Enschede

UMC Groningen, Groningen

Medisch Centrum Leeuwarden, Leeuwarden

Maasstad Ziekenhuis, Rotterdam

Den Haag Ziekenhuis, The Hague

Spain

Hospital Clínico de Barcelona, Barcelona

Lucas Augusti Hospital, Lugo

Hospital Clínico Universitario of Valladolid, Valladolid

Hospital Álvaro Cunqueiro Vigo, Vigo

United Kingdom

Barts Health NHS Trust, London, London

Freeman Hospital, Newcastle

University Hospitals Southampton, Southampton